Gavi, the Vaccine Alliance, aims to accelerate access to COVID-19 vaccines around the world, with intelligent finance operations.
Call for change
Providing equitable access to COVID-19 vaccines around the world is on the minds of many but requires the agility and rigor around operations for many organizations.
Gavi, the Vaccine Alliance is partnering with Accenture to support finance operations for its COVAX Facility, a multilateral initiative with the aim of accelerating equitable access to COVID-19 vaccines around the world.
The goal of COVAX, which is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), is to distribute two billion COVID-19 vaccines by the end of 2021.
When tech meets human ingenuity
With operational excellence critical to this ambition, Accenture will enhance the agility and rigor of Gavi’s operations with the support of its finance specialists.
As part of the initiative, Accenture will work with Gavi to define the right operating model and standardized processes for working across alliance partners, manufacturers, governments and other organizations. Accenture will also support grant accounting, financial planning, budgeting and management reporting. Its specialists will enable Gavi to adjust and scale capacity as demand changes.
A valuable difference
As the initiative progresses, Accenture and Gavi will also look to enhance operational rigor across service management and governance processes to improve transactional-level quality, performance monitoring and visibility across enterprise processes.
Accenture has been focused on an effort to help organizations pivot to future-ready operations, transforming how work gets done across technology, processes and people to boost efficiency and speed to value.
"We will expand our capacity to allow COVAX participants and partners to plan and manage with greater efficiency and accountability, supporting our goal of global equitable access to COVID-19 vaccines."